48 related articles for article (PubMed ID: 23286397)
1. [Murine model of Graves disease induced by thyroid-stimulating hormone receptor gene transfected via liposome].
Long W; Qiu LH; Meng C; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Dec; 34(6):550-5. PubMed ID: 23286397
[TBL] [Abstract][Full Text] [Related]
2. [An exploration of induction methodology and experimental duration of Graves disease animal model].
Wu LP; Shi BY; Xun LR; Guo LY; Yang J; Xu L
Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):793-7. PubMed ID: 23290979
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus encoding the thyrotropin receptor A-subunit improves the efficacy of dendritic cell-induced Graves' hyperthyroidism in mice.
Mizutori Y; Saitoh O; Eguchi K; Nagayama Y
J Autoimmun; 2006 Feb; 26(1):32-6. PubMed ID: 16242303
[TBL] [Abstract][Full Text] [Related]
4. Immunization of mice with a newly identified thyroid-stimulating hormone receptor splice variant induces Graves'-like disease.
Endo T; Kobayashi T
J Autoimmun; 2013 Jun; 43():18-25. PubMed ID: 23538203
[TBL] [Abstract][Full Text] [Related]
5. Experimental model for ophthalmopathy in BALB/c and outbred (CD-1) mice genetically immunized with G2s and the thyrotropin receptor.
Yamada M; Li AW; West KA; Chang CH; Wall JR
Autoimmunity; 2002 Sep; 35(6):403-13. PubMed ID: 12568121
[TBL] [Abstract][Full Text] [Related]
6. Induction of hyperthyroidism in mice by intradermal immunization with DNA encoding the thyrotropin receptor.
Barrett K; Liakata E; Rao PV; Watson PF; Weetman AP; Lymberi P; Banga JP; Carayanniotis G
Clin Exp Immunol; 2004 Jun; 136(3):413-22. PubMed ID: 15147342
[TBL] [Abstract][Full Text] [Related]
7. Enhanced response to mouse thyroid-stimulating hormone (TSH) receptor immunization in TSH receptor-knockout mice.
Nakahara M; Mitsutake N; Sakamoto H; Chen CR; Rapoport B; McLachlan SM; Nagayama Y
Endocrinology; 2010 Aug; 151(8):4047-54. PubMed ID: 20555026
[TBL] [Abstract][Full Text] [Related]
8. [Establishment of an animal model for thyroid associated ophthalmopathy by treatment of mice with human thyrotropin receptors-activated splenocytes].
Zhang L; Liu C; Zhang H; He Y; Zhan SH
Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1073-7. PubMed ID: 17415963
[TBL] [Abstract][Full Text] [Related]
9. Examination of orbital tissues in murine models of Graves' disease reveals expression of UCP-1 and the TSHR in retrobulbar adipose tissues.
Johnson KT; Wiesweg B; Schott M; Ehlers M; Müller M; Minich WB; Nagayama Y; Gulbins E; Eckstein AK; Berchner-Pfannschmidt U
Horm Metab Res; 2013 Jun; 45(6):401-7. PubMed ID: 23386414
[TBL] [Abstract][Full Text] [Related]
10. Induction of experimental autoimmune Graves' disease in BALB/c mice.
Kaithamana S; Fan J; Osuga Y; Liang SG; Prabhakar BS
J Immunol; 1999 Nov; 163(9):5157-64. PubMed ID: 10528222
[TBL] [Abstract][Full Text] [Related]
11. The significance of immune-related molecule expression profiles in an animal model of Graves' disease.
Ye F; Hou P; Wu X; Ma X; Gao L; Wu L; Xu L; Shi B
Autoimmunity; 2012 Mar; 45(2):143-52. PubMed ID: 22017306
[TBL] [Abstract][Full Text] [Related]
12. An improved method for the establishment of a model of Graves' disease in BALB/c mice.
Zheng W; Wang R; Tan J; Li N; Meng Z
Mol Med Rep; 2017 Apr; 15(4):1471-1478. PubMed ID: 28259898
[TBL] [Abstract][Full Text] [Related]
13. An improved mouse model of Graves disease by once immunization with Ad-TSHR289.
Tang Y; Zhu X; Feng H; Zhu L; Fu S; Kong B; Liu X
Endocr J; 2019 Sep; 66(9):827-835. PubMed ID: 31217394
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with a biologically active ICAM-1 mAb and an siRNA targeting TSHR in a BALB/c mouse model of Graves' disease.
Wang X; Liu W; Rui Z; Zheng W; Tan J; Li N; Yu Y
Endokrynol Pol; 2021; 72(6):592-600. PubMed ID: 34647608
[TBL] [Abstract][Full Text] [Related]
15. TSH receptor-adenovirus-induced Graves' hyperthyroidism is attenuated in both interferon-gamma and interleukin-4 knockout mice; implications for the Th1/Th2 paradigm.
Nagayama Y; Saitoh O; McLachlan SM; Rapoport B; Kano H; Kumazawa Y
Clin Exp Immunol; 2004 Dec; 138(3):417-22. PubMed ID: 15544617
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of experimental Graves' disease by intranasal administration of a T cell epitope of the thyrotropin receptor.
Arima T; Shimojo N; Yamaguchi K; Tomiita M; Kohn LD; Kohno Y
Clin Immunol; 2008 Apr; 127(1):7-13. PubMed ID: 18234558
[TBL] [Abstract][Full Text] [Related]
17. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease.
Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ
Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477
[TBL] [Abstract][Full Text] [Related]
18. Clinical associations of the genetic variants of CTLA-4, Tg, TSHR, PTPN22, PTPN12 and FCRL3 in patients with Graves' disease.
Gu LQ; Zhu W; Zhao SX; Zhao L; Zhang MJ; Cui B; Song HD; Ning G; Zhao YJ
Clin Endocrinol (Oxf); 2010 Feb; 72(2):248-55. PubMed ID: 19438904
[TBL] [Abstract][Full Text] [Related]
19. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto's who developed Graves' disease and pretibial myxoedema.
Kamath C; Young S; Kabelis K; Sanders J; Adlan MA; Furmaniak J; Rees Smith B; Premawardhana LD
Clin Endocrinol (Oxf); 2012 Sep; 77(3):465-70. PubMed ID: 22891608
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated gene delivery of interleukin-10, but not transforming growth factor beta, ameliorates the induction of Graves' hyperthyroidism in BALB/c mice.
Saitoh O; Mizutori Y; Takamura N; Yamasaki H; Kita A; Kuwahara H; Nagayama Y
Clin Exp Immunol; 2005 Sep; 141(3):405-11. PubMed ID: 16045729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
